ARCHIVES

FDA Approves Abraxane For Second-Line Treatment Of Metastatic Breast Cancer

This article is from The Cancer Letter archive.

Vol. 28 No. 1 | January 28, 2005

Download PDF Visit The Full Archive

Related Articles

Advisors Discuss NCI Intramural Program In Closed Session, Defend Process

December 16, 1994

“We’re All Filling Up With Carcinogens” Ames Tells NCAB

October 7, 1977

TTF Increased Survival Compared To Chemotherapy

December 31, 2010

William Nelson Named Cancer Center Director At Johns Hopkins.

November 7, 2008

NCI Cooperative Group, Cancer Center Trials Listed

June 27, 2008

Give Young Women Data, Not Guidelines, Advisors Tell NCI; consensus For Over 50

October 29, 1993